C4 Therapeutics, Inc. (CCCC)
2.92
-0.05
(-1.68%)
USD |
NASDAQ |
May 06, 16:00
2.92
0.00 (0.00%)
After-Hours: 20:00
C4 Therapeutics Profit Margin (Quarterly) : -186.0% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc. | 18.75% |
| Biogen, Inc. | 13.29% |
| Merck & Co., Inc. | -26.19% |
| Bristol Myers Squibb Co. | 23.31% |
| BrightSpring Health Services, Inc. | 2.06% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -52.70% |
| Return on Assets | -32.75% |
| Return on Invested Capital | -40.05% |
| Gross Profit Margin (Quarterly) | 83.61% |
| Operating Margin (Quarterly) | -210.1% |
| Return on Net Operating Assets | -175.5% |